Physician profile
Ziad Ali
NPI 1730386871
$10,052.39
in general payments reported to CMS, 2019-2025
10 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $550 · 2021: $3,998 · 2022: $702 · 2023: $13.14 · 2024: $4,186 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $382.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $9,462.75 | 2019-2024 | |
| Biohorizons Implant Systems INC. | $165.50 | 2024 | Biohorizons |
| Pacira Pharmaceuticals Incorporated | $140.19 | 2019-2024 | Exparel |
| Vertex Pharmaceuticals Incorporated | $124.95 | 2025 | |
| Medtronic, INC. | $58.07 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $44.46 | 2022 | |
| Geistlich Pharma, North America, INC. | $15.74 | 2020 | |
| Philips North America LLC | $14.44 | 2020 | |
| Ace Surgical Supply Co., INC. | $13.15 | 2021 | |
| Southern Implants North America INC | $13.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.